Coping with TB immune reconstitution inflammatory syndrome

Area of Science:

• Immunology
• Infectious Diseases
• HIV/AIDS

Background:

• Tuberculosis immune reconstitution inflammatory syndrome (TB IRIS) is a common complication in patients coinfected with HIV and TB who initiate highly active antiretroviral therapy (HAART).
• TB IRIS presents in two forms: paradoxical (worsening of treated TB) and unmasking (newly apparent TB).
• The pathogenesis of TB IRIS involves heightened immune responses to Mycobacterium tuberculosis following HAART initiation, though it remains incompletely understood.

Purpose of the Study:

• To discuss the pathogenesis of TB IRIS.
• To explore treatment and prevention strategies for TB IRIS.

Main Methods:

• This study is a discussion-based review of existing literature on TB IRIS.
• Key aspects of pathogenesis, clinical presentation, risk factors, and management options are synthesized.

Main Results:

• TB IRIS is primarily diagnosed through clinical observation, with no specific laboratory tests currently available for diagnosis or prediction.
• Identified risk factors for TB IRIS include low CD4(+) lymphocyte counts, disseminated TB at HAART initiation, and a short interval between TB treatment and HAART initiation.

Conclusions:

• TB IRIS poses significant challenges to the management of HIV-TB coinfected patients.
• Further research into pathogenesis is needed to develop targeted diagnostic and therapeutic interventions.